The global Allergy Diagnostics Marketwas valued at USD 2.43 billion in 2016 and is projected to reach USD 5.63billion by 2025, growing at a CAGR of 9.78% from 2017 to 2025.
Effective management of allergic diseases relies on the ability to make an accurate diagnosis. Allergy testing can help confirm or rule out allergies. Correct diagnosis, counseling, and avoidance advice based on valid allergy test results reduces the incidence of symptoms and need for medications, and improves quality of life.With increasing environmental population and large effect of epigenetic factors affecting health of population, the need of correct and efficient allergy diagnostics has increased. The market is currently in a growing trend.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increased Cases of allergic diseases and high expenses
1.2 Rising pollution and lifestyle changes
1.3 Increasing expenditure in healthcare
1.4 Allergy diagnosis insurance more easy to access in the US
2. Market Restraints
2.1 Medical equipment is high costed
2.2 Less awareness regarding allergic diseases
Market Segmentation:
1. Global Allergy Diagnostics Market, by Products and services:
1.1 Product
1.1.1 Assay Kits
1.1.2 Instruments
1.1.2.1 Immunoassay Analyzers
1.1.2.2 Luminometers
1.1.2.3 Elisa Analyzers
1.1.2.4 Other Instruments
1.2 Services
2. Global Allergy Diagnostics Market, by Allergen:
2.1 Inhaled Allergens
2.2 Food Allergens
2.3 Drug Allergens
2.4 Other Allergens
3. Global Allergy Diagnostics Market, by Test:
3.1 In vivo
3.2 In vitro
4. Global Allergy Diagnostics Market, by End User:
4.1 Diagnostic Laboratories
4.2 Hospital-Based Laboratories
4.3 Academic Research Institutes
4.4 Other End Users
5. Global Allergy Diagnostics Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Thermo Fisher Scientific Inc.
2. Siemens AG
3. Danaher Corporation
4. Omega Diagnostics Group PLC
5. Hitachi Chemical Co., Ltd.
6. Biomérieux SA
7. Stallergenes Greer
8. Hob Biotech Group Suzhou Co., Ltd.
9. Hycor Biomedical, Inc.
10. Lincoln Diagnostics, Inc.
11. R-Biopharm AG.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Allergy Diagnostics Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL ALLERGY DIAGNOSTICS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL ALLERGY DIAGNOSTICS MARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES
5.1 Overview
5.2 Product
5.2.1 Assay Kits
5.2.2 Instruments
5.2.3 Immunoassay Analyzers
5.2.4 Luminometers
5.2.5 Elisa Analyzers
5.2.6 Other Instruments
5.3 Services
6 GLOBAL ALLERGY DIAGNOSTICS MARKET, BY ALLERGENS
6.1 Overview
6.2 Inhaled Allergens
6.3 Food Allergens
6.4 Drug Allergens
6.5 Other Allergens
7 GLOBAL ALLERGY DIAGNOSTICS MARKET, BY TEST
7.1 Overview
7.2 In vivo
7.3 In vitro
8 GLOBAL ALLERGY DIAGNOSTICS MARKET, BY END USER
8.1 Overview
8.2 Diagnostic Laboratories
8.3 Hospital-Based Laboratories
8.4 Academic Research Institutes
8.5 Other End Users
9 GLOBAL ALLERGY DIAGNOSTICS MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 â€" 2025
10 GLOBAL ALLERGY DIAGNOSTICS MARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies
11 COMPANY PROFILES
11.1 Thermo Fisher Scientific Inc.
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 Siemens AG
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 Danaher Corporation
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Omega Diagnostics Group PLC
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 Hitachi Chemical Co., Ltd.
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 Biomérieux SA
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 Stallergenes Greer
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 Hob Biotech Group Suzhou Co., Ltd.
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 Hycor Biomedical, Inc.
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments
11.10 Lincoln Diagnostics, Inc.
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments
11.11 R-Biopharm AG.
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Developments
12 Appendix
12.1 Related Reports